Table 4.
IRHCTT documented complications as of May 2013 (percentage of total complications).33
| Metabolic complications (52.5%) | |
|---|---|
| Hyperglycemia | 20 |
| Increased creatinine values | 9 |
| Arterial hypertension | 6 |
| Avascular necrosis of the hip | 2 |
| Leukopenia | 2 |
| Cushing syndrome | 1 |
| Hyperparathyroidism | 1 |
| End-stage renal disease | 1 |
| Opportunistic infections (45%) | |
| Bacterial | 14 (one osteitis, three graft connective tissue infections) |
| Cytomegalovirus (CMV) | 10 |
| Cutaneous mycosis | 5 |
| Herpes virus (HSV) | 3 |
| Clostridium difficile | 2 |
| Herpes zoster virus (HZV) | 1 |
| Epstein-Barr virus (EBV) | 1 |
| Malignancies (2.5%) | |
| Basal cell carcinoma of nose | 1 |
| Lymphoproliferative disease | 1 |